2.500EUR+4.60%Mkt Cap: 29.74M EURP/E: 24.10Last update: 2026-05-14
genOway Société anonyme, a biotechnology company, engages in the development and commercialization of custom genetically modified mouse, rat, and cell line models worldwide. It produces customized mouse models, such as k…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)24.10
P/E (Forward)16.07
PEG—
P/B1.32
P/S1.42
EV/EBITDA—
EV/Revenue—
EPS (TTM)0.10
EPS (Forward)0.15
Cash Flow & Leverage
FCF Yield—
FCF Margin—
Operating CF5.38M EUR
CapEx (TTM)2.39M EUR
Net Debt/EBITDA—
Net Debt6.72M EUR
Technical
SMA 502.449 (+2.1%)
SMA 2002.617 (-4.5%)
Beta0.40
S&P 52W Chg24.23%
Avg Vol (30d)9.46K
Avg Vol (10d)17.91K
Technical Indicators
RSI (14)53.5
MACD0.0026
MACD Signal0.0012
MACD Hist.+0.0014
BB Upper2.565 EUR
BB Middle2.466 EUR
BB Lower2.366 EUR
BB Width8.04%
ATR (14)0.1087 EUR
Vol Ratio (20d)0.28x
52W Range
2.10029% of range3.500
52W High3.500 EUR
52W Low2.100 EUR
Profitability
Gross Margin48.44%
EBITDA Margin0.00%
Profit Margin8.30%
Oper. Margin19.61%
ROE9.86%
ROA5.76%
Revenue Growth-43.40%
Earnings Growth—
Balance Sheet
Debt/Equity0.30
Current Ratio8.26
Quick Ratio5.68
Book Value/Sh1.832 EUR
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Ownership
Shares Out.12.34M
Float—
Insiders7.76%
Institutions15.86%
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Company
Market Cap29.74M EUR
Enterprise Value—
Revenue (TTM)20.96M EUR
Gross Profit10.68M EUR
Net Income (TTM)1.83M EUR
Revenue/Share—
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
Last Price2.500 EUR
CountryFR
SectorHealthcare
IndustryBiotechnology
ISINFR0004053510